Pulmonx Gross Margin 2019-2025 | LUNG
Current and historical gross margin for Pulmonx (LUNG) over the last 10 years. The current gross profit margin for Pulmonx as of September 30, 2025 is %.
| Pulmonx Gross Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Gross Profit | Gross Margin |
| 2025-09-30 | $0.09B | $0.07B | 72.04% |
| 2025-06-30 | $0.09B | $0.07B | 72.53% |
| 2025-03-31 | $0.09B | $0.06B | 72.73% |
| 2024-12-31 | $0.08B | $0.06B | 73.81% |
| 2024-09-30 | $0.08B | $0.06B | 73.42% |
| 2024-06-30 | $0.08B | $0.06B | 72.73% |
| 2024-03-31 | $0.07B | $0.05B | 73.97% |
| 2023-12-31 | $0.07B | $0.05B | 73.91% |
| 2023-09-30 | $0.07B | $0.05B | 73.85% |
| 2023-06-30 | $0.06B | $0.05B | 73.77% |
| 2023-03-31 | $0.06B | $0.04B | 72.41% |
| 2022-12-31 | $0.05B | $0.04B | 72.22% |
| 2022-09-30 | $0.05B | $0.04B | 71.70% |
| 2022-06-30 | $0.05B | $0.04B | 73.08% |
| 2022-03-31 | $0.05B | $0.04B | 74.00% |
| 2021-12-31 | $0.05B | $0.04B | 75.00% |
| 2021-09-30 | $0.04B | $0.03B | 75.00% |
| 2021-06-30 | $0.04B | $0.03B | 71.43% |
| 2021-03-31 | $0.03B | $0.02B | 64.71% |
| 2020-12-31 | $0.03B | $0.02B | 61.76% |
| 2020-06-30 | $0.02B | $0.01B | 59.09% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.084B | $0.084B |
| Pulmonx Corporation is a medical technology company. It designs, develops, manufactures and markets minimally invasive medical devices for the diagnosis and treatment of chronic obstructive pulmonary diseases. Pulmonx Corporation is based in Redwood City, California. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $39.471B | 45.65 |
| Tempus AI (TEM) | United States | $11.790B | 0.00 |
| Doximity (DOCS) | United States | $8.244B | 33.95 |
| Hims & Hers Health (HIMS) | United States | $7.214B | 58.69 |
| IRhythm Technologies (IRTC) | United States | $5.781B | 0.00 |
| Hinge Health (HNGE) | United States | $3.772B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $2.859B | 47.30 |
| Privia Health (PRVA) | United States | $2.834B | 177.23 |
| Heartflow (HTFL) | United States | $2.822B | 0.00 |
| 10x Genomics (TXG) | United States | $2.589B | 0.00 |
| Omnicell (OMCL) | United States | $2.277B | 46.55 |
| Azenta (AZTA) | United States | $1.744B | 71.55 |
| Enovis (ENOV) | United States | $1.697B | 8.91 |
| Schrodinger (SDGR) | United States | $1.355B | 0.00 |
| Clover Health Investments (CLOV) | United States | $1.343B | 0.00 |
| Phreesia (PHR) | United States | $1.039B | 0.00 |
| Butterfly Network (BFLY) | United States | $1.021B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.861B | 0.00 |
| Talkspace (TALK) | United States | $0.666B | 134.00 |
| Standard BioTools (LAB) | United States | $0.592B | 0.00 |
| Claritev (CTEV) | United States | $0.478B | 0.00 |
| Evolent Health (EVH) | United States | $0.465B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.384B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.358B | 0.00 |
| Carlsmed (CARL) | United States | $0.337B | 0.00 |
| TruBridge (TBRG) | United States | $0.323B | 14.83 |
| Senseonics Holdings (SENS) | United States | $0.295B | 0.00 |
| CapsoVision (CV) | United States | $0.286B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.262B | 0.00 |
| Insight Molecular Diagnostics (IMDX) | United States | $0.213B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.175B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.174B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.154B | 0.00 |
| CareCloud (CCLD) | United States | $0.129B | 7.09 |
| EUDA Health Holdings (EUDA) | Singapore | $0.087B | 0.00 |
| American Well (AMWL) | United States | $0.085B | 0.00 |
| Outset Medical (OM) | United States | $0.083B | 0.00 |
| HeartBeam (BEAT) | United States | $0.083B | 0.00 |
| NetraMark Holdings (AINMF) | Canada | $0.068B | 0.00 |
| Retrieve Medical Holdings (RMHI) | United States | $0.068B | 0.00 |
| Precipio (PRPO) | United States | $0.043B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.042B | 0.00 |
| 111 (YI) | China | $0.027B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.023B | 0.00 |
| Lunai Bioworks (LNAI) | United States | $0.022B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.020B | 0.00 |
| Zhongchao (ZCMD) | China | $0.014B | 0.00 |
| HeartSciences (HSCS) | United States | $0.010B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.009B | 0.00 |
| PROFUSA (PFSA) | United States | $0.008B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.008B | 0.00 |
| Movano (MOVE) | United States | $0.006B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.003B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.002B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.001B | 0.00 |